Jeff Yass’s Sutro Biopharma STRO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-11,100
Closed -$369K – 14492
2026
Q2
$369K Buy
+11,100
New +$346K ﹤0.01% 10599
2022
Q3
– Sell
-6,790
Closed -$354K – 14084
2022
Q2
$354K Buy
+6,790
New +$379K ﹤0.01% 9115
2021
Q2
– Sell
-1,660
Closed -$378K – 13239
2021
Q1
$378K Sell
1,660
-3,620
-69% -$859K ﹤0.01% 10113
2020
Q4
$1.15M Buy
+5,280
New +$874K ﹤0.01% 6398

Other funds holding STRO

Jeff Yass's STRO Position: Q3 2026 in Review

Jeff Yass sold out of Sutro Biopharma (STRO) in Q3 2026, closing a stake of 8,426 shares — an estimated $280K sold.

Jeff Yass first reported a position in STRO in Q1 2021 and held it in 20 quarters. The position peaked at $2.11M in Q1 2026. 107 funds tracked by Wall St. Rank hold STRO as of Q3 2026.

  • Jeff Yass reported no remaining Sutro Biopharma position as of Q3 2026 after selling out during the quarter.
  • Jeff Yass sold 8,426 Sutro Biopharma shares in Q3 2026, an estimated $280K.
  • Jeff Yass first reported a position in Sutro Biopharma in Q1 2021 and held it in 20 quarters.
  • Jeff Yass's Sutro Biopharma position peaked at $2.11M in Q1 2026.
  • 107 funds tracked by Wall St. Rank held Sutro Biopharma as of Q3 2026.

Based on Susquehanna International Group's 13F filing for Q3 2026, filed 16 Nov 2026.